BioSpace News Archive

Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (PAD), today announced that the Company received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its Ocelaris next generation image-guided chronic total occlusion (CTO) crossing system

Genovate Biotech (TPEX:4130) subsidiary and Taiwan-based focused ultrasound (FUS) manufacturer NaviFUS Corporation is pleased to announce the start of its clinical trial (NCT04446416) for the combination of FUS plus bevacizumab therapy

CEL-SCI Corporation (NYSE American: CVM), a Phase 3 cancer immunotherapy company, today announced that it will be presenting at the H.C. Wainwright 22nd Annual Global Investment Conference.

Perimeter Medical Imaging AI, Inc. (TSXV:PINK; FSE:4PC), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need, announced today that Jeremy Sobotta, Perimeter’s President and CFO will present a company overview at the H.C. Wainwright & Co. 22nd Annual Global Investment (Virtual) Conference

Patients Who Achieved SDI at Any Timepoint Maintained it at All Future Timepoints; Higher Proportion of Patients Showing SDI with Increasing Dose Patients Achieving SDI Also Demonstrated Trend Toward Improvement in Fatigue and Physical Function at 12 Months First Available Data from Open Label Expansion Show Patients with SDI at 12 Months, Maintained SDI at Later Time Points Conference Call and Webcast Today, September 11, 2020 at 8:30

Molecular diagnostics company Genetic Technologies Ltd (ASX: GTG; NASDAQ: GENE, “Company”) is delighted to announce that initial sales of its GeneType for Breast Cancer Risk Assessment have now commenced in the United States via an online health platform, elicity by InTeleLabs, an independent telehealth and personalised medicine company.

Jaguar Health, Inc. (NASDAQ:JAGX) announced today announced that Lisa Conte, Jaguar’s founder, president and CEO, will present at the virtual 2020 H.C. Wainwright 22nd Annual Global Investment Conference on Wednesday, September 16, 2020, at 3:00 p.m. Eastern Time.

Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company developing therapeutics that modulate the endocannabinoid system, today announced that it will be presenting at the H.C. Wainwright Annual Global Investment Conference, being held virtually on September 14-16, 2020.

Rising Biosciences, Inc. (OTC PINK:RBII) CEO Arthur Hall noted the resumption of trading of RBII stock and announced the Environmental Protection Agency (EPA) has issued Establishment Number 96322-OH-3 for the company’s new 10,000 square foot bottling plant and corporate headquarters in Sandusky, OH.

Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) announces that it has filed its annual financial statements for the year ended April 30, 2020, related MD&A and annual information form pursuant to National Instrument 51-102 (collectively, the “Annual Filings”).